Invention Grant
- Patent Title: Triazolothiadiazole inhibitor of c-Met protein kinase
- Patent Title (中): 三硝基噻二唑抑制剂c-Met蛋白激酶
-
Application No.: US13099643Application Date: 2011-05-03
-
Publication No.: US08343998B2Publication Date: 2013-01-01
- Inventor: David J. Lauffer , Pan Li , Dean Shannon , Jianglin Liang
- Applicant: David J. Lauffer , Pan Li , Dean Shannon , Jianglin Liang
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Daniel A. Pearson
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61P35/00
Abstract:
The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders.
Public/Granted literature
- US20110207774A1 TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE Public/Granted day:2011-08-25
Information query
IPC分类:
